Keros Therapeutics, Inc. (KROS)
11.12
-0.56
(-4.79%)
USD |
NASDAQ |
Aug 26, 16:00
11.10
-0.02
(-0.18%)
After-Hours: 20:00
Keros Therapeutics Total Return Level : 11.12 for Aug. 26, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 26, 2026 | 11.12 |
| August 25, 2026 | 11.68 |
| August 24, 2026 | 10.78 |
| August 21, 2026 | 11.03 |
| August 20, 2026 | 10.95 |
| August 19, 2026 | 11.10 |
| August 18, 2026 | 10.61 |
| August 17, 2026 | 10.48 |
| August 14, 2026 | 10.10 |
| August 13, 2026 | 10.66 |
| August 12, 2026 | 11.20 |
| August 11, 2026 | 10.64 |
| August 10, 2026 | 10.69 |
| August 07, 2026 | 11.15 |
| August 06, 2026 | 10.65 |
| August 05, 2026 | 9.995 |
| August 04, 2026 | 10.25 |
| August 03, 2026 | 10.11 |
| July 31, 2026 | 10.07 |
| July 30, 2026 | 10.22 |
| July 29, 2026 | 9.97 |
| July 28, 2026 | 10.07 |
| July 27, 2026 | 10.21 |
| July 24, 2026 | 10.06 |
| July 23, 2026 | 10.14 |
| Date | Value |
|---|---|
| July 22, 2026 | 10.21 |
| July 21, 2026 | 10.57 |
| July 20, 2026 | 10.61 |
| July 17, 2026 | 10.64 |
| July 16, 2026 | 10.61 |
| July 15, 2026 | 11.03 |
| July 14, 2026 | 10.57 |
| July 13, 2026 | 11.10 |
| July 10, 2026 | 11.80 |
| July 09, 2026 | 12.03 |
| July 08, 2026 | 11.67 |
| July 07, 2026 | 11.65 |
| July 06, 2026 | 11.03 |
| July 02, 2026 | 11.26 |
| July 01, 2026 | 10.88 |
| June 30, 2026 | 10.70 |
| June 29, 2026 | 10.93 |
| June 26, 2026 | 10.99 |
| June 25, 2026 | 10.41 |
| June 24, 2026 | 10.92 |
| June 23, 2026 | 11.00 |
| June 22, 2026 | 10.98 |
| June 18, 2026 | 10.65 |
| June 17, 2026 | 10.41 |
| June 16, 2026 | 10.03 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Incyte Corp. | 128.12 |
| Nurix Therapeutics, Inc. | 26.71 |
| ACADIA Pharmaceuticals, Inc. | 29.58 |
| Alnylam Pharmaceuticals, Inc. | 239.00 |
| Anika Therapeutics, Inc. | 21.68 |